Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

• Status: Completed
• Trial end date: 2014-08-01

Summary

The purpose of this study is to evaluate the effects of Ceftazidime Avibactam compared to Doripenem for treating hospitalized patients with complicated urinary tract infections, including acute pyelonephritis

• Phase: Phase 3

Details

• Lead Sponsor: AstraZeneca; Pfizer
• Collaborator: Forest Laboratories
• Treatments: Avibactam; Avibactam, ceftazidime drug combination; Ceftazidime; Ciprofloxacin; Doripenem; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination